Neogen Corporation
Loading chart...
Loading financial statements...
Financial statements
data from SEC XBRL filings. Values are as-reported; restatements supersede originals. Values reported in .
| Line item |
|---|
| Period ending |
Recent insider activity
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-08-04 | Nassif Mikheal indirect | CEO | Buy | +370 | $11.81 | $4,370 |
Source: SEC Form 4 filings.
Next expected filings
- ~2027-01-08 10-Q expected by 2027-01-08 (in 93 days)
- ~2027-04-09 10-Q expected by 2027-04-09 (in 184 days)
- ~2027-07-30 10-K expected by 2027-07-30 (in 296 days)
- ~2027-10-07 10-Q expected by 2027-10-07 (in 365 days)
Predicted from historical filing cadence; not an SEC commitment.
Recent SEC filings
- 2026-10-07 10-Q Quarterly Report
- 2026-10-06 8-K Earnings Release; Financial Statements and Exhibits
- 2026-08-21 DEF 14A Proxy Statement
- 2026-08-07 8-K Officer/Director Change
- 2026-07-30 8-K Earnings Release; Financial Statements and Exhibits
- 2026-07-30 10-K Annual Report
- 2026-04-09 10-Q Quarterly Report
- 2026-04-09 8-K Earnings Release; Financial Statements and Exhibits
- 2026-03-30 8-K Officer/Director Change
- 2026-01-08 10-Q Quarterly Report
- 2026-01-08 8-K Earnings Release; Financial Statements and Exhibits
- 2025-10-30 8-K Officer/Director Change; Other Events; Financial Statements and Exhibits
- 2025-10-28 8-K/A Officer/Director Change; Financial Statements and Exhibits
- 2025-10-09 10-Q Quarterly Report
- 2025-10-09 8-K Earnings Release; Financial Statements and Exhibits